Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
14 Febbraio 2024 - 3:00PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO
FILED
PURSUANT TO RULE 13d-2(b)
(AMENDMENT NO. 2)*
BIOMERICA, INC.
(Name of Issuer)
Common Stock, par
value $0.08
(Title of Class of Securities)
09061H307
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
____________________
| * | The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page. |
| | The information required in the remainder of this cover page shall not be deemed to be
“filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). |
CUSIP NO. 09061H307 |
13G |
Page 2 of 5 Pages |
1 |
NAMES OF REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Granahan Investment Management LLC |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) [ ]
(b) [ ] |
3 |
SEC USE ONLY
|
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
State of Massachusetts |
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5 |
SOLE VOTING POWER
929,042 |
|
6 |
SHARED VOTING POWER
None |
|
7 |
SOLE DISPOSITIVE POWER
1,082,672 |
|
8 |
SHARED DISPOSITIVE POWER
None |
|
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,082,672 |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
[ ] |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.44% |
|
12 |
TYPE OF REPORTING PERSON
IA |
|
|
|
|
|
|
CUSIP
NO. 09061H307 |
13G |
Page 3 of 5 Pages |
| Item 1. | (a) |
Name of Issuer: |
BIOMERICA, INC
| (b) | Address of Issuer’s Principal Executive Offices: |
17571 Von Karman Avenue
Irvine, CA 92614
| Item 2. | (a) |
Name of Person Filing: |
Granahan Investment Management LLC
| (b) | Address of Principal Business Office or, if None, Residence: |
Wyman Street, Suite 460
Waltham, MA 02451
State of Massachusetts
| (d) | Title of Class of Securities: |
Common Stock, par value $0.08
09061H307
| Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person
Filing is a: |
| (a) | [ ] Broker or dealer registered under Section 15 of the Exchange Act. |
| (b) | [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. |
| (c) | [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. |
| (d) | [ ] Investment company registered under Section 8 of the Investment Company Act. |
| (e | [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
| (f) | [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); |
| (g) | [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
| (h) | [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
| (i) | [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act; |
| (j) | [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). |
CUSIP
NO. 09061H307 |
13G |
Page 4 of 5 Pages |
|
|
|
(a) |
Amount beneficially owned: |
1,082,672 |
(b) |
Percent of class: |
6.44% |
(c) |
Number of shares as to which the person has: |
|
|
(i) |
Sole power to vote or to direct the vote: |
929,042 |
|
(ii) |
Shared power to vote or to direct the vote: |
0 |
|
(iii) |
Sole power to dispose or to direct the disposition of: |
1,082,672 |
|
(iv) |
Shared power to dispose or to direct the disposition of: |
0 |
| Item 5. | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report
the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class
of securities, check the following. [ ]
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
All of the Shares set forth in Item 4 are
owned by various investment advisory clients of Granahan Investment Management LLC, which is deemed to be a beneficial owner of those
shares pursuant to Rule 13d-3 under the Securities Exchange Act of 1934, due to its discretionary power to make investment decisions over
such shares and/or its ability to vote such shares.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by
the Parent Holding Company or Control Person. |
Not applicable
| Item 8. | Identification and Classification of Members of the Group. |
Not applicable
| Item 9. | Notice of Dissolution of Group. |
Not applicable
CUSIP NO. 09061H307 |
13G |
Page 5 of 5 Pages |
By signing below the undersigned
certifies that, to the best of my knowledge and belief, the securities referred to above were acquired and held in the ordinary course
of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect.
Signature
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
Granahan Investment Management LLC |
|
|
|
|
|
|
By: |
/s/ Brian Granahan |
|
|
Name: |
Brian Granahan |
|
|
Title: |
Chief Compliance Officer |
|
|
|
|
|
|
Date: |
February 14, 2024 |
|
Grafico Azioni Biomerica (NASDAQ:BMRA)
Storico
Da Ott 2024 a Dic 2024
Grafico Azioni Biomerica (NASDAQ:BMRA)
Storico
Da Dic 2023 a Dic 2024